Drugs / Peri-OLIMEL 2.5% E
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02632630 Comparator | Mar 2016 → Feb 2018 | nutritional deficiency disease | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peri-OLIMEL 2.5% E | “of pre-packaged Peri-OLIMEL 2.5% E.” NCT02632630 ↗ |
| Route | Intravenous | “through a peripheral vein” NCT02632630 ↗ |